Our finding that the ELK4‐SP1/3 complex cooperatively regulates gene expression to promote CRC tumor growth raises the intriguing possibility that the combination of a MEK/ERK inhibitor with an SP1 inhibitor might lead to a synergistic inhibitory effect on CRC growth. This evidence concerns the gene MAPK1 and colorectal carcinoma.